NASDAQ:AMED
Amedisys Inc Stock News
$90.78
-0.180 (-0.198%)
At Close: Apr 18, 2024
Amedisys (AMED) Misses Q3 Earnings and Revenue Estimates
06:49pm, Wednesday, 26'th Oct 2022
Amedisys (AMED) delivered earnings and revenue surprises of -7.26% and 3.41%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Stocks to Watch From the Pandemic-Hit Outpatient Home Health Industry
12:47pm, Thursday, 29'th Sep 2022
Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. AMED, ADUS and HNGR are w
Here's Why Investors Should Retain Amedisys (AMED) Stock for Now
12:02pm, Friday, 23'rd Sep 2022
Investors are optimistic about Amedisys' (AMED) better-than-expected earnings and notable buyouts.
Amedisys Inc (AMED) CEO Chris Gerard on Q2 2022 Results - Earnings Call Transcript
05:10pm, Thursday, 28'th Jul 2022
Amedisys Inc (NASDAQ:AMED ) Q2 2022 Earnings Conference Call July 28, 2022 11:00 AM ET Company Participants Nick Muscato - Chief Strategy Officer Chris Gerard - President and Chief Executive Officer S
Amedisys (AMED) Q2 Earnings Beat Estimates
07:21pm, Wednesday, 27'th Jul 2022
Amedisys (AMED) delivered earnings and revenue surprises of 19.51% and 4.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Amedisys Announces Second Quarter 2022 Earnings Release and Conference Call Date
08:00am, Wednesday, 06'th Jul 2022
BATON ROUGE, La., July 06, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the s
Amedisys' (AMED) New Tie Up to Boost At-Home Patient Care
01:06pm, Tuesday, 28'th Jun 2022
Amedisys (AMED) strengthens its Home Health and Hospice business reach by partnering with Memorial Hermann.
Amedisys (AMED) Contessa's New JV Broadens At-Home Care Range
11:17am, Friday, 10'th Jun 2022
Amedisys' (AMED) latest initiative aims at providing patients with a high-quality continuum of care in the home.
Analyst Ratings for Amedisys
06:38pm, Friday, 27'th May 2022 Benzinga
Over the past 3 months, 5 analysts have published their opinion on Amedisys (NASDAQ:AMED) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a compan
Amedisys (AMED) Down 11% Since Last Earnings Report: Can It Rebound?
05:12pm, Friday, 27'th May 2022 Zacks Investment Research
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Amedisys (AMED) Down 11% Since Last Earnings Report: Can It Rebound?
02:19pm, Friday, 27'th May 2022
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Retain Amedisys (AMED) Stock for Now
02:38pm, Wednesday, 25'th May 2022 Zacks Investment Research
Investors are optimistic about the robust performances of Amedisys' (AMED) Home Health and Hospice segments.
Here's Why You Should Retain Amedisys (AMED) Stock for Now
12:18pm, Wednesday, 25'th May 2022
Investors are optimistic about the robust performances of Amedisys' (AMED) Home Health and Hospice segments.
Amedisys to Present at Multiple Healthcare Conferences in June
12:00pm, Wednesday, 25'th May 2022 GlobeNewswire Inc.
BATON ROUGE, La., May 25, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Chris Gerard, P
Amedisys to Present at Multiple Healthcare Conferences in June
08:00am, Wednesday, 25'th May 2022
BATON ROUGE, La., May 25, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Chris Gerard, Pre
